Carcinoma-in-situ of the Testis: Possible Origin From Gonocytes and Precursor of All Types of Germ Cell Tumours Except Spermatocytoma

Int J Androl. 1987 Feb;10(1):19-28. doi: 10.1111/j.1365-2605.1987.tb00161.x.

Abstract

Based on evidence from morphological and histochemical studies and from clinical experience, the following hypotheses are proposed: carcinoma-in-situ (CIS) germ cells are malignant gonocytes; these CIS gonocytes have some capacity to regress into more primitive, totipotent embryonic cells which can give rise to all types of nonseminomatous germ cell tumours; the tumour germ cells of classical seminomas are malignant gonocytes derived from CIS gonocytes which have lost their ability to regress into totipotent embryonic cells; the ability of CIS gonocytes to regress into totipotent embryonic cells decreases with age, whereas the capacity to form classical seminoma cells is preserved; the transformation of CIS gonocytes into invasive tumours is dependent on factors such as gonadotrophins and/or testicular steroids; the pathogenesis of classical and spermatocytic seminoma are unrelated. As a consequence of these hypotheses an alternative nomenclature for carcinoma-in-situ, seminoma and dysgerminoma is suggested.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma in Situ / pathology*
  • Dysgerminoma / pathology
  • Humans
  • Male
  • Neoplasm Invasiveness
  • Neoplasms, Germ Cell and Embryonal / pathology
  • Spermatozoa / cytology*
  • Testicular Neoplasms / pathology*